Australian Industry Welcomes Possible Oral Contraceptive Switch
In a move welcomed by industry, the Australian Labor Party has pledged it would task if elected the country’s federal drug administration, the TGA, to advise on options to improve access to the oral contraceptive pill.
You may also be interested in...
Australia's Therapeutic Goods Administration has introduced a set of criteria introducing additional controls for medicines rescheduled from ‘Schedule 4’ (prescription-only) to ‘Schedule 3’ (non-prescription, pharmacist-only) status, intended to facilitate more innovative prescription-to-OTC switches in the future.
In this first installment of an exclusive three-part series, global switch expert Dr Natalie Gauld speaks to HBW Insight about what makes a country an attractive environment for switching and highlights those markets leading the way today.
The Australian Self Medication Industry (ASMI) is calling for IP protection for successful prescription-to-OTC reclassification applications to encourage switching in Australia.